Oral Mucosal Graft Versus Labial Graft in Female Urethroplasty
NCT ID: NCT07153861
Last Updated: 2025-09-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
40 participants
INTERVENTIONAL
2025-02-26
2026-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison Between Two Techniques Used in Treatment of Long Anterior Urethral Stricture
NCT05918315
Effect of Pelvic Organ Prolapse Surgeries on Female Sexual Function in Egyptian Women
NCT03498443
Saline Sonohystrography and Office Hysteroscopy in Evaluation of Cases of Abnormal Uterine Bleeding
NCT03135353
Comparison Between Glandular Urethral Disassembly Versus Tubularized Incised Plate for Primary Distal Hypospadius Repair
NCT05913128
Gastric Ultrasound in Elective Surgical Diabetic Patients
NCT06600035
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Urethral reconstruction may become the treatment of choice in stricture recurrence following the failure of minimally invasive procedures. and the use of flaps and grafts has all been proposed. Different materials (e.g., vaginal and genital mucosal graft or flap, bladder mucosal flap, and oral mucosal graft) have been reported for augmentation urethroplasty.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
Patients will be admitted for the surgical management by the oral mucosal graft urethroplasty with the anterior onlay technique.
Oral mucosal graft
Patients will be admitted for the surgical management by the oral mucosal graft urethroplasty with the anterior onlay technique.
Group 2
Patients will be admitted for the surgical management by the labial graft urethroplasty with the anterior onlay technique.
Labial graft
Patients will be admitted for the surgical management by the labial graft urethroplasty with the anterior onlay technique.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Oral mucosal graft
Patients will be admitted for the surgical management by the oral mucosal graft urethroplasty with the anterior onlay technique.
Labial graft
Patients will be admitted for the surgical management by the labial graft urethroplasty with the anterior onlay technique.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Female patients with non-traumatic urethral stricture.
Exclusion Criteria
* Female patients with systemic contraindications of surgery like bleeding disorders.
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tanta University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mohamed Ibrahim Ahmed Elmaadawy
Lecturer of Urology, Faculty of Medicine, Tanta University, Tanta, Egypt.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tanta University
Tanta, El-Gharbia, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
36264PR1113/2/25
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.